Jiaxin Yin | Medicine | Best Researcher Award

Best Researcher Award

Jiaxin Yin
Tianjin University of Traditional Chinese Medicine, China

Jiaxin Yin
Affiliation Tianjin University of Traditional Chinese Medicine
Country China
Scopus ID 57224629998
Documents 25
Citations 411
h-index 10
Subject Area Medicine
Event International Research Hypothesis Excellence Award

Jiaxin Yin, affiliated with Tianjin University of Traditional Chinese Medicine in China, is a medicine researcher whose scholarly record includes 25 indexed documents, 411 citations, and an h-index of 10 according to the supplied Scopus author information.[1] Recent research associated with Yin includes work on the authentication of Curcumae Radix using DNA barcoding and headspace gas chromatography–ion mobility spectrometry, as well as research applying network pharmacology, cell membrane chromatography, and high-performance liquid chromatography to identify candidate antidepressant compounds from Cyperus rotundus L.[2][3]

Abstract

The Best Researcher Award profile recognizes Jiaxin Yin of Tianjin University of Traditional Chinese Medicine for a documented research record in medicine. The supplied bibliometric information reports 25 documents, 411 citations, and an h-index of 10.[1] Yin’s recent publications demonstrate interests at the intersection of traditional medicine, analytical science, molecular identification, pharmacological screening, and natural-product research. In particular, the reported 2026 work on Curcumae Radix combines DNA barcoding with HS-GC-IMS to support botanical authentication, while another 2026 study describes an integrated screening strategy for identifying candidate antidepressant compounds from Cyperus rotundus L.[2][3]

Keywords

Jiaxin Yin; Best Researcher Award; Tianjin University of Traditional Chinese Medicine; Medicine; Traditional Chinese Medicine; DNA Barcoding; Curcumae Radix; HS-GC-IMS; Network Pharmacology; Cell Membrane Chromatography; Natural Products; Antidepressant Compounds.

Introduction

Research in traditional medicine increasingly incorporates analytical chemistry, molecular biology, pharmacology, and computational approaches to improve the identification, authentication, and evaluation of medicinal materials. Within this broader research environment, Jiaxin Yin’s reported publication record includes studies that employ complementary experimental and analytical methodologies to investigate medicinal resources and bioactive compounds.[2][3]

The reported scholarly profile provides quantitative evidence of sustained publication activity and citation reach, while the available recent publications provide qualitative evidence of interdisciplinary research interests. The combination of botanical authentication, chromatographic analysis, DNA-based identification, network pharmacology, and compound screening reflects a research direction relevant to contemporary medicine and traditional medicine research.[1]

Research Profile

Jiaxin Yin is affiliated with Tianjin University of Traditional Chinese Medicine, China, and is identified in the supplied information under the subject area of Medicine. The reported Scopus author identifier is 57224629998. The supplied bibliometric record lists 25 documents, 411 citations, and an h-index of 10.[1]

  • Affiliation: Tianjin University of Traditional Chinese Medicine
  • Country: China
  • Subject Area: Medicine
  • Indexed Documents: 25
  • Total Citations: 411
  • h-index: 10
  • Scopus Author ID: 57224629998

Research Contributions

The supplied publication information indicates research contributions spanning medicinal-plant authentication and pharmacologically oriented screening. One reported study addresses the authentication of Curcumae Radix, an important medicinal material, through a combined molecular and analytical strategy. DNA barcoding provides a molecular approach for distinguishing botanical materials, while HS-GC-IMS contributes chemical-volatile profiling information, allowing complementary evidence to be considered in the authentication process.[2]

Publications

The following publications were supplied as representative recent research outputs associated with Jiaxin Yin. Bibliographic details are presented without adding DOI information that was not supplied.

  1. Q. Jiang, J. Yin, X. Han, M. Song, B. Xiang, et al. (2026). Authentication of the Botanical Origins of Curcumae Radix Based on DNA Barcoding and HS-GC-IMS. Rapid Communications in Mass Spectrometry.
  2. M. Liu, W. Wang, Y. Zhang, L. He, H. Yu, et al. (2026). An integrated multitarget screening strategy combining network pharmacology with cell membrane chromatography coupled to high-performance liquid chromatography for identifying candidate antidepressant compounds from Cyperus rotundus L. Journal of Ethnopharmacology.

Research Impact

The supplied bibliometric record reports 411 citations and an h-index of 10 across 25 documents, providing measurable indicators of the visibility and scholarly use of the researcher’s publications.[1] Bibliometric indicators should be interpreted in relation to field, publication age, collaboration patterns, and disciplinary citation practices rather than as standalone measures of research quality.

From a methodological perspective, the reported research contributes to approaches for authenticating medicinal materials and investigating candidate bioactive compounds. Such work can support reproducibility and quality assessment in traditional medicine research by combining molecular identification, chemical profiling, chromatographic analysis, and computational approaches.[2][3]

Award Suitability

Based on the supplied information, Jiaxin Yin’s profile is relevant for consideration for the Best Researcher Award associated with the International Research Hypothesis Excellence Award. The principal supporting factors are the documented publication output, citation record, h-index, and evidence of recent interdisciplinary research in medicine.[1]

  • Established scholarly output represented by 25 reported indexed documents.
  • A reported citation count of 411 and h-index of 10.
  • Research activity within the medicine and traditional medicine domain.
  • Recent interdisciplinary work involving DNA barcoding, HS-GC-IMS, network pharmacology, chromatography, and analytical chemistry.
  • Publication activity addressing medicinal-material authentication and candidate therapeutic compound identification.

Conclusion

Jiaxin Yin’s supplied academic profile combines a substantial reported citation record with research activity in medicine and traditional Chinese medicine. The reported publications demonstrate the use of complementary molecular, analytical, chromatographic, and computational methods to investigate medicinal materials and candidate bioactive compounds.[1][2][3] On the evidence provided, the profile presents relevant characteristics for consideration under a Best Researcher Award framework, while final recognition should remain dependent on formal review and verification.

References

  1. Elsevier. (n.d.). Scopus author details: Jiaxin Yin, Author ID 57224629998. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57224629998
  2. Jiang, Q., Yin, J., Han, X., Song, M., Xiang, B., et al. (2026). Authentication of the Botanical Origins of Curcumae Radix Based on DNA Barcoding and HS-GC-IMS. Rapid Communications in Mass Spectrometry.
  3. Liu, M., Wang, W., Zhang, Y., He, L., Yu, H., et al. (2026). An integrated multitarget screening strategy combining network pharmacology with cell membrane chromatography coupled to high-performance liquid chromatography for identifying candidate antidepressant compounds from Cyperus rotundus L. Journal of Ethnopharmacology.

Shiji Fang | Medicine | Best Researcher Award

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation Lishui Central Hospital
Country China
Scopus ID 57192204982
Documents 91
Citations 2,574
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

  • Primary discipline: Medicine.
  • Institutional affiliation: Lishui Central Hospital, China.
  • Scopus Author ID: 57192204982.
  • Indexed documents: 91.
  • Reported citations: 2,574.
  • Reported h-index: 27.
  • Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

  1. Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
  2. Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
  3. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
  4. Corrigendum to β€œFangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
    https://www.scopus.com/pages/authors/57192204982
  2. Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
    https://doi.org/10.1016/j.freeradbiomed.2025.07.047
  3. Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
    https://doi.org/10.1002/advs.202517792
  4. Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
    https://doi.org/10.1186/s12951-025-03722-2
  5. Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
    https://doi.org/10.1016/j.actbio.2025.04.042
  6. Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
    https://doi.org/10.1021/acsami.4c21890

sang ho choi | Medicine and Health Sciences | Best Researcher Award

sang ho choi | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr sang ho choi, Kwangwoon University, South Korea

Assist. Prof. Dr. Sang Ho Choi is an expert in biomedical engineering and artificial intelligence, currently serving as an Assistant Professor at Kwangwoon University, Seoul, Korea πŸ‡°πŸ‡·. He leads the Healthcare & AI Lab πŸ§ πŸ€–. Previously, he worked as a Staff Engineer at Samsung Research πŸ“±. Dr. Choi earned his Ph.D. in Biomedical Engineering from Seoul National University πŸŽ“, focusing on sleep monitoring using deep neural networks πŸ˜΄πŸ”. His research interests include biomedical signal processing, AI for healthcare, and IoT systems 🌐. He has published extensively on sleep engineering, neural networks, and health monitoring technologies πŸ“ŠπŸ“š.

Publication Profile

Orcid

Education

Assist. Prof. Dr. Sang Ho Choi is a skilled academic with a Ph.D. in Biomedical Engineering from Seoul National University (2014–2020), where he specialized in unconstrained sleep monitoring and modulation using deep neural networks and closed-loop stimulation. He conducted his research under the guidance of Prof. Kwang Suk Park. Prior to this, he earned a B.S. in Bio-mechatronic Engineering, with a double major in Electronic and Electrical Engineering, from Sungkyunkwan University (2009–2014). He was mentored by Prof. Chang Hyun Choi and Prof. Jitae Shin. His work integrates bioengineering and innovative neural network technologies. πŸ§ πŸ’»πŸŽ“

Experience

The research initiatives include groundbreaking work in neuro-chip design and neuro-computing platforms, simulating the human nervous system, funded by the Ministry of Science and ICT (MSIT) Korea (Jul 2022 – Dec 2029) as Co-PI. Another project focuses on intelligent biomedical wireless power transfer, under the National Research Foundation of Korea (NRF) (Mar 2022 – Feb 2024), also as Co-PI. Additionally, the development of AI-based vital signal and sleep monitoring technology using UWB radar is being led as PI (Jul 2021 – Feb 2023) by the NRF. These innovative efforts aim to revolutionize healthcare technology. πŸ§ πŸ’‘πŸ“‘πŸ€–

Research Interest

Assist. Prof. Dr. Sang Ho Choi specializes in biomedical signal processing and analysis, with a strong focus on Artificial Intelligence (AI) applications for biomedical engineering and deep learning. His research spans areas like sleep engineering, healthcare systems, and the integration of Internet of Things (IoT) systems to enhance healthcare outcomes. By leveraging advanced AI techniques, Dr. Choi explores innovative solutions for improving diagnostics, treatment processes, and patient care efficiency. His work aims to merge technology with healthcare, contributing significantly to the future of smart, data-driven medical systems. πŸ§ πŸ’‘πŸ©ΊπŸ€–πŸ’»

Ongoing Projects

Assist. Prof. Dr. Sang Ho Choi is a Co-PI on significant national projects funded by Korea’s MSIT and NRF, leading innovative research in the fields of neuro-chip design and AI-driven health monitoring technologies. His work is shaping the future of healthcare by integrating advanced neurotechnology with artificial intelligence. With a passion for cutting-edge scientific advancements, Dr. Choi’s contributions are paving the way for transformative breakthroughs in medical devices and digital health. His dedication to improving healthcare through technological innovation continues to inspire and drive progress in the industry. πŸ§ πŸ’‘πŸ€–πŸ’ŠπŸ”¬

Research Focus

Assist. Prof. Dr. Sang Ho Choi’s research primarily focuses on biomedical signal processing and health monitoring using advanced sensor technologies. His work includes exploring wearable devices for sleep monitoring, studying the functional connectivity of the amygdala in chronic insomnia patients, and utilizing spiking neural networks for analyzing biomedical signals. He also investigates real-time detection systems, like apnea-hypopnea event detection using radar sensors, and continues to push the boundaries of sensor-based health technologies. His contributions extend to neuroengineering and biomedical engineering, aiming to enhance the accuracy and efficiency of health monitoring systems. πŸ§ πŸ“‘πŸ’‘πŸ’€πŸ‘©β€βš•οΈ

Publication Top Notes